Pharmacogenomics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
Pharmacogenomics is the individualisation of drug therapies to patients using their genetic information. Sequencing a patients genome allows genetic variations to be identified, such as single nucleotide polymorphism. Tailoring treatment to an individual increases the effectiveness and reduces the chance of adverse side effects | Pharmacogenomics is the individualisation of drug therapies to patients using their [[Genetic information|genetic information]]. Sequencing a patients [[Genome|genome]] allows [[Genetic variation|genetic variations]] to be identified, such as [[SNP|single nucleotide polymorphism]]. Tailoring treatment to an individual increases the effectiveness and reduces the chance of adverse side effects <ref>American Medical Association, 2014. Pharmacogenomics [online] Available at: &amp;lt;http://www.ama-assn.org/ama/pub/physician-resources/medical-science/genetics-molecular-medicine/current-topics/pharmacogenomics.page&amp;gt; Accessed:[16/10/14]</ref>. | ||
=== | === References === | ||
<references /> | |||
Latest revision as of 01:17, 17 October 2014
Pharmacogenomics is the individualisation of drug therapies to patients using their genetic information. Sequencing a patients genome allows genetic variations to be identified, such as single nucleotide polymorphism. Tailoring treatment to an individual increases the effectiveness and reduces the chance of adverse side effects [1].
References
- ↑ American Medical Association, 2014. Pharmacogenomics [online] Available at: &lt;http://www.ama-assn.org/ama/pub/physician-resources/medical-science/genetics-molecular-medicine/current-topics/pharmacogenomics.page&gt; Accessed:[16/10/14]